Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.9840
-0.0013 (-0.13%)
At close: Oct 7, 2026, 4:00 PM EDT
1.005
+0.021 (2.17%)
After-hours: Oct 7, 2026, 7:06 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $15.66 million as of October 7, 2026. That makes Allarity Therapeutics the world's 38,844th most valuable company and 5,394th in the United States. Its market cap has decreased by 34.67% in one year.
Market Cap
15.66M
Enterprise Value
20.96M
1-Year Change
-34.67%
Global Rank
Country Rank
#5,394 United States
Category
ChartMarket Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $15.66M, a decrease of -80.28%. That is a compound annual growth rate of -28.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 15.66M | -8.26% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 17.51M |
| Palatin Technologies | 17.01M |
| Akari Therapeutics, | 16.98M |
| Lipocine | 16.90M |
| Cellectar Biosciences | 16.82M |
| Dyadic International | 16.61M |
| NewcelX | 16.46M |
| Kiora Pharmaceuticals | 16.29M |